A novel open source tool for ELISA result analysis

Danielak, Dorota; Banach, G.; Walaszczyk, Juliusz; Romański, Michał; Bawiec, Marek A.; Paszkowska, Jadwiga; Zielińska, Maryla; Sczodrok, Jaroslaw; Wiater, Marcela; Hoc, Dagmara; Kołodziej, Bartosz; Garbacz, Grzegorz

doi:10.1016/j.jpba.2020.113415

Cited by 4 publications

(1 citation statement)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The subsequent step includes the testing and optimization of assay conditions such as incubation times, temperature, and reagent conditions [ 25 , 26 ]. The evaluation must aim at the viral genome, for example, the RdRp, N, E, and S genes [ 27 , 28 , 29 ]. RT-PCR allows early, specific, and sensitive viral detection because it directly detects RNA and enhances the genomic material, although only a low level of the viral RNA is present in the collected biological specimens [ 30 ].…”

Section: Traditional Techniques and Current Diagnostic Strategiesmentioning

confidence: 99%

State-of-the-Art Smart and Intelligent Nanobiosensors for SARS-CoV-2 Diagnosis

et al. 2022

View full text Add to dashboard Cite

The novel coronavirus appeared to be a milder infection initially, but the unexpected outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), commonly called COVID-19, was transmitted all over the world in late 2019 and caused a pandemic. Human health has been disastrously affected by SARS-CoV-2, which is still evolving and causing more serious concerns, leading to the innumerable loss of lives. Thus, this review provides an outline of SARS-CoV-2, of the traditional tools to diagnose SARS-CoV-2, and of the role of emerging nanomaterials with unique properties for fabricating biosensor devices to diagnose SARS-CoV-2. Smart and intelligent nanomaterial-enabled biosensors (nanobiosensors) have already proven their utility for the diagnosis of several viral infections, as various detection strategies based on nanobiosensor devices are already present, and several other methods are also being investigated by researchers for the determination of SARS-CoV-2 disease; however, considerably more is undetermined and yet to be explored. Hence, this review highlights the utility of various nanobiosensor devices for SARS-CoV-2 determination. Further, it also emphasizes the future outlook of nanobiosensing technologies for SARS-CoV-2 diagnosis.

show abstract

Section: Traditional Techniques and Current Diagnostic Strategiesmentioning

confidence: 99%

State-of-the-Art Smart and Intelligent Nanobiosensors for SARS-CoV-2 Diagnosis

et al. 2022

View full text Add to dashboard Cite

show abstract

Enzyme-Linked Immunosorbent Assay (ELISA)

Tabatabaei

Ahmed

2022

Methods in Molecular Biology

View full text Add to dashboard Cite

ORBIS project – where have we arrived?

Skotnicki,

Jakubowska,

Smułek

et al. 2023

JMS

View full text Add to dashboard Cite

The Open Research Biopharmaceutical Internships Support project (ORBIS) was a response to the scientific, economic, and social challenge of increasing the effectiveness and productivity of the drug development process, both for innovative and (super)generic drugs. The overarching objective of the ORBIS project was to form a transnational and intersectoral cooperation network of academic and industrial organisations delivering a joint research programme. The research aimed at improving the preclinical pathway of drug development and manufacturing, focusing on technological and methodological improvements of the existing processes. The participating staff from all institutions have developed new skills, were exposed to new work and research environments, and have significantly broadened their career perspectives. More than 450 months of secondments were completed, and over 175 early-stage and experienced researchers participated in the exchange. This review aims to present some aspects of the scientific, training, and organisational activities of the consortium, bringing together representatives of both the academic sector as well as small and medium-sized pharmaceutical enterprises.

show abstract

A novel open source tool for ELISA result analysis

Cited by 4 publications

References 23 publications

State-of-the-Art Smart and Intelligent Nanobiosensors for SARS-CoV-2 Diagnosis

State-of-the-Art Smart and Intelligent Nanobiosensors for SARS-CoV-2 Diagnosis

Enzyme-Linked Immunosorbent Assay (ELISA)

ORBIS project – where have we arrived?

Contact Info

Product

Resources

About